Top 50 Medical Device Startup Investors in China (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Qiming Venture Partners
VC Fund
|
13 | China, United States, Hong Kong | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5M–$142M |
|
Cowin Capital
VC Fund
|
13 | China, Hong Kong, United States | Series A, Series B, Seed | Manufacturing, Health Care, Biotechnology | $1.4M–$50M |
|
HSG
VC Fund
|
12 | China, United States, Hong Kong | Series A, Series B, Series C | Health Care, Biotechnology, Software | $4.4M–$214M |
|
Shunwei Capital
VC Fund
|
11 | China, United States, India | Series A, Series B, Series C | Manufacturing, Software, Internet | $1.4M–$130M |
|
BioVenture
VC Fund
|
11 | China, United States, Hong Kong | Series A, Series B, Seed | Health Care, Medical, Biotechnology | $1.6M–$73M |
|
CD Capital
VC Fund
|
10 | China, United States | Series A, Series B, Seed | Health Care, Biotechnology, Medical Device | $1.4M–$34M |
|
Lilly Asia Ventures
VC Fund
|
10 | China, United States, Hong Kong | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $14M–$259M |
|
BIOCHING CAPITAL
VC Fund
|
9 | China | Angel, Series A, Seed | Medical Device, Medical, Biotechnology | $425k–$100M |
|
BioTrack Capital
VC Fund
|
9 | China, United States, Singapore | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $3M–$168M |
|
IDG Capital
VC Fund
|
8 | China, United States, India | Series A, Series B, Series C | Software, Internet, E-Commerce | $3M–$190M |
|
Haibang Capital
VC Fund
|
8 | China | Series A, Angel, Series B | Health Care, Biotechnology, Manufacturing | $425k–$71M |
|
Taiyu Investment
VC Fund
|
7 | China | Seed, Series A, Angel | Medical, Health Care, Biotechnology | $4.3M–$37M |
|
Addor Capital
VC Fund
|
7 | China, Hong Kong, Singapore | Series A, Series B | Manufacturing, Semiconductor, Electronics | $1.4M–$43M |
|
Legend Capital
VC Fund
|
7 | China, United States, South Korea | Series B, Series A, Series C | Health Care, Medical, Biotechnology | $2.8M–$200M |
|
Jan Hammer
Angel
|
7 | China, United States, France | Series A, Series B, Seed | Health Care, Medical, Medical Device | $2.5M–$250M |
|
Prox Ventures
VC Fund
|
7 | China, United States, United Kingdom | Seed, Series A | Medical, Biotechnology, Health Care | $1.9M–$28M |
|
Med-Fine Capital
VC Fund
|
7 | China, Hong Kong, United States | Series A, Seed, Series B | Medical, Health Care, Biotechnology | $2.8M–$60M |
|
Dalton Venture
VC Fund
|
7 | China, India, Canada | Seed, Series A, Series B | Health Care, Medical, Biotechnology | $450k–$47M |
|
EFung Capital
VC Fund
|
7 | China, United States, India | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $1.4M–$130M |
|
Marathon Venture Partners
VC Fund
|
6 | China, United States, Hong Kong | Series A, Series B, Seed | Health Care, Medical, Biotechnology | $1.4M–$462M |
|
Matrix Partners China
VC Fund
|
6 | China, United States, Hong Kong | Series A, Series B, Series C | Health Care, Biotechnology, Software | $2.8M–$200M |
|
Share Capital
VC Fund
|
6 | China, United States, Colombia | Series A, Series B, Seed | Health Care, Medical, Biotechnology | $142k–$57M |
|
Oriza Seed Capital (Oriza Yuandian)
VC Fund
|
6 | China, United States, Singapore | Series A, Seed, Angel | Manufacturing, Health Care, Biotechnology | $213k–$90M |
|
CDH Investments
VC Fund
|
6 | China, United States, Canada | Series A, Series B, Series C | Manufacturing, Health Care, Biotechnology | $8.3M–$300M |
|
SZHTI Group
VC Fund
|
5 | China, United States | Series A, Angel | Manufacturing, Electronics, Semiconductor | $425k–$14M |
|
Oriza Holdings
VC Fund
|
5 | China, United States, Canada | Series A, Series B, Series C | Manufacturing, Health Care, Biotechnology | $1.7M–$200M |
|
Sunland Fund
VC Fund
|
5 | China | Series B, Series A, Seed | Medical, Health Care, Medical Device | $1.4M–$28M |
|
SND Ventures Group
VC Fund
|
5 | China | Series A, Series B, Seed | Manufacturing, Semiconductor, Health Care | $709k–$90M |
|
Goldport Capital
VC Fund
|
5 | China | Series A, Seed, Angel | Manufacturing, Medical, Semiconductor | $425k–$55M |
|
Apricot Capital
VC Fund
|
5 | China, United States, Hong Kong | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $3M–$58M |
|
Fortune Venture Capital
VC Fund
|
5 | China, Japan, United States | Series A, Series B, Seed | Manufacturing, Software, Information Technology | $425k–$73M |
|
HY Capital
VC Fund
|
4 | China, United States | Series A, Seed, Series B | Health Care, Medical, Medical Device | $199k–$28M |
|
Frees Fund
VC Fund
|
4 | China, United States, Singapore | Series A, Seed, Angel | Artificial Intelligence, Health Care, Biotechnology | $425k–$35M |
|
Green Pine Capital Partners
VC Fund
|
4 | China, United States, Canada | Series A, Series B, Angel | Biotechnology, Software, Manufacturing | $425k–$150M |
|
Volcanics Venture
VC Fund
|
4 | China, United States, Hong Kong | Series A, Series B | Health Care, Artificial Intelligence, Biotechnology | $425k–$60M |
|
Insight Capital
VC Fund
|
4 | China, Thailand, United Kingdom | Series A, Seed, Series C | Health Care, Medical, Medical Device | $2.8M–$100M |
|
ASBV
VC Fund
|
4 | China, Australia, Hong Kong | Seed, Series A, Angel | Health Care, Medical, Biotechnology | $425k–$31M |
|
Qiaojing Capital
VC Fund
|
4 | China | Series A, Series B, Angel | Health Care, Medical, Medical Device | $1.4M–$35M |
|
Highlight Capital
VC Fund
|
4 | China, United States, Portugal | Series A, Series B, Seed | Health Care, Medical, Biotechnology | $2.8M–$84M |
|
Huagai Capital
VC Fund
|
4 | China, United States, Germany | Series A, Series B, Angel | Health Care, Biotechnology, Medical | $425k–$90M |
|
Tasly Capital
VC Fund
|
4 | China | Series B, Series A, Seed | Medical, Medical Device, Health Care | $14M–$43M |
|
Co-Stone Venture Capital
VC Fund
|
3 | China, United States, Hong Kong | Series B, Series A, Series C | Manufacturing, Semiconductor, Health Care | |
|
Jolmo Capital
VC Fund
|
3 | China, Japan, United States | Series A, Seed, Series B | Health Care, Manufacturing, Medical | |
|
ZSVC
VC Fund
|
3 | China, United States, India | Series A, Seed, Series B | Manufacturing, Health Care, Medical | |
|
CMB International Capital Corporation
VC Fund
|
3 | China, United States, Japan | Series B, Series A, Series C | Biotechnology, Manufacturing, Health Care | |
|
Qingrong Ventures
VC Fund
|
3 | China | Seed, Angel | Medical, Medical Device, Health Care | |
|
Yuanhui Chuangyi
VC Fund
|
3 | China | Seed, Series A | Medical Device, Beauty, Industrial | |
|
Long Hill Capital
VC Fund
|
3 | China, United States | Series A, Series B, Angel | Medical, Health Care, Medical Device | |
|
Tiantu Capital
VC Fund
|
3 | China, United States, Japan | Series A, Series B, Series C | Food and Beverage, E-Commerce, Health Care | |
|
Jinding Capital
VC Fund
|
3 | China | Series A, Series B, Seed | Manufacturing, Health Care, Pet | |
| Access all 1115 investors in China Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 716
- Round size: Series A $5M–$64M; Series B $10M–$100M; Series C $15M–$142M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — raised $887M in 2023
Portfolio highlights
- Fitlens — Fitlens
- Duet — Duet is a dating application helps you find meaningful relationships based on shared interests and experiences.
- Woof — Woof is a street fashion community and e-commerce platform for young generations.
Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, Hong Kong, United States
Investor stats
- Total investments: 264
- Round size: Seed $1.4M–$20M; Series A $4.3M–$43M; Series B $2.8M–$50M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $75M in 2014
Portfolio highlights
- HUAUN — HUAUN is a security vendor that focuses on vulnerability management and AI offense and defense.
- Sinsegye — Sinsegye operates as a product-driven enterprise company. Sinsegye is an industrial control supercomputing infrastructure supplier.
- Digital China — Digital China is a robotics company focused on developing humanoid interactive robots that can break traditional boundaries and create emotionally resonated partners.
We help founders build enduring companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 751
- Round size: Series A $4.4M–$100M; Series B $12M–$200M; Series C $26M–$214M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- MarqVision — Effortlessly discover and remove counterfeits to protect your sales and reputation.
- Midas — Midas is the first neobroker of Turkey, providing zero commission Turkish and American stocks.
- Yunzhou Zhiwei — Yunzhou Zhiwei is a high-tech startup focused on serving large-scale equipment maintenance industries such as aviation, aerospace, shipbuilding, and rail transit. It leverages smart maintenance concepts and advanced digital technologies to make complex equipment maintenance more efficient and lean. The company drives industrial transformationtoward intelligent maintenance, helping enterprises enhance growth, efficiency, and operational excellence.
Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.
Show more...Investment focus
- Industry: Manufacturing, Software, Internet
- Stage:Series A, Series B, Series C
- Geography: China, United States, India
Investor stats
- Total investments: 408
- Round size: Series A $1.4M–$41M; Series B $8.2M–$50M; Series C $20M–$130M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $1.2B in 2018
Portfolio highlights
- CertiK — CertiK, the largest Web3 security service provider, uses AI and formal verification to protect and monitor smart contracts and protocols, securing the Web3 ecosystem.
- Darma — DARMA - Digital Healt
- LibLib AI — LibLib AI is an AI image generation platform that provides cutting-edge content creation through multi-scenario and multi-dimensional applications and interactions. It is a subsidiary of Beijing Singularity Star Technology Co., Ltd.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 151
- Round size: Seed $1.6M–$20M; Series A $1.9M–$42M; Series B $3M–$73M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Dami&Xiaomi — Rice and millet is China's leading platform services for children with autism spectrum, from 2014 Nian 9 Yue Jiang Ying Shuang (rice) founded the "rice and millet" micro-channel public number. It now provides integrated services such as rehabilitation services, integrated education support, parent training, online courses, andpopular science information.
- CART Medical — CART Medical Technologies, Ltd. is a high-tech company specializing in the development and application of new technologies for immune cell therapy. It has a 2,200 square meter GMP laboratory and research and development laboratory.
- Ubiquitin Bio — Ubiquitin Bio is a research and development manufacturer of in vitro diagnostic products.
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Seed
- Geography: China, United States
Investor stats
- Total investments: 67
- Round size: Seed $1.4M–$14M; Series A $1.4M–$27M; Series B $7.1M–$34M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Pipi Bear —
- Senas Medical — Senas Medical focuses on innovative cardiac electrophysiology solutions.
- Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 209
- Round size: Series A $14M–$100M; Series B $25M–$112M; Series C $28M–$259M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $40M in 2019
Portfolio highlights
- Passage Bio — Passage Bio, a genetic medicines company, is changing the future of CNS disorders and transforming the lives of patients and their families.
- Langlai Technology — Langlai Technology is a clinical-stage innovative drug research and development company. Adhering to the dual-drive strategy of synchronously improving the R&D pipeline and platform construction, it has built a full-process new drug R&D process from concept verification, candidate compound screening, preclinical druggability development toclinical research. system.
- Alebund Pharmaceuticals — Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions.
BIOCHING CAPITAL is an investment management firm.
Show more...Investment focus
- Industry: Medical Device, Medical, Biotechnology
- Stage:Angel, Series A, Seed
- Geography: China
Investor stats
- Total investments: 20
- Round size: Angel $425k–$100M; Series A $14M–$14M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Lunke Medical — Lunke Medical focuses on the research, development, production, and sales of medical devices, with particular strength and expertise in high-pressure technologies. The company is committed to delivering safe, reliable, and innovative solutions by combining advanced engineering, strict quality control, and continuous technological advancement tomeet the evolving needs of the medical industry.
- Taose Tuantuan — Taose Tuantua is a sex toy company that primarily offers TAOSETT sex toy academy and exquisite sex toy community store services.
- Qinglan Jichuang — Qinglan Jichuang is a domestic high-performance intelligent endoscope innovative enterprise.
BioTrack Capital invests in early and growth stage companies within life sciences, healthcare technology, biotechnology and related high-tech sectors, providing capital and investment support for innovation. The firm evaluates scientific and commercial potential of ventures and structures financings aimed at advancing technologies from earlyresearch to market engagement. Its activities include sourcing opportunities, conducting due diligence, and working with founders and management teams to align growth strategies with investor objectives. BioTrack Capital also participates in funding rounds alongside co-investors to support development of novel healthcare and tech solutions. The company engages with portfolio companies through strategic interaction and monitoring of progress toward business milestones.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: China, United States, Singapore
Investor stats
- Total investments: 84
- Round size: Seed $14M–$168M; Series A $3M–$43M; Series B $14M–$150M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- PrinoPharma — PrinoPharma focuses on developing novel druggable sites targeting difficult-to-drug or existing druggable targets.
- Huihe Healthcare — Huihe Healthcare specializes in the development of medical devices for structural heart disease. The company was founded in 2019 and is headquartered in Shanghai, China.
- Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
IDG Capital is a global investment firm partnering with founders to build enduring businesses through capital, expertise, and long-term support.
Show more...Investment focus
- Industry: Software, Internet, E-Commerce
- Stage:Series A, Series B, Series C
- Geography: China, United States, India
Investor stats
- Total investments: 705
- Round size: Series A $3M–$112M; Series B $7.4M–$142M; Series C $14M–$190M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Polymaker — Polymaker is a high quality 3D printing filament manufacturers. PLA, PETG, ABS, ASA, TPU, Nylon, PC, Carbon Fiber and more. Find the best filament for your application.
- Ripple — Discover why hundreds of financial institutions choose Ripple to provide a better international payments experience for their customers in real-time.
- Singularity Energy Technology — Singularity Energy is committed to core technology research and product development in advanced energy storage systems, and contributes industry-leading solutions to promote large-scale clean energy integration and achieve global carbon neutrality goals.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Series A, Angel, Series B
- Geography: China
Investor stats
- Total investments: 40
- Round size: Angel $425k–$2.8M; Series A $1.4M–$14M; Series B $10M–$71M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- XPTC — XPTC is a wafer slicing equipment developer, dedicated to the research, development, production, and sales of ultra-precision thinning cutting equipment and related consumables.
- Wuwen Zhike — Wuwen Zhixing is an intelligent driving service provider dedicated to offering professional and cutting-edge integrated solutions for AI data and simulation verification, as well as developing AI data infrastructure and accelerators.
- Huashen Ruili — Huashen Ruili is a manufacturer and retailer of auto parts. It focuses on the advancement of drive motor systems' dry brake-by-wire technology.
Taiyu Investment is an investment firm.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed, Series A, Angel
- Geography: China
Investor stats
- Total investments: 23
- Round size: Seed $4.3M–$7.4M; Series A $14M–$37M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Immunocan — Immunocan focuses on the development of fully human antibody animals, artificial chromosome carriers with independent intellectual property rights, focusing on tumor treatment, and developing antibody therapeutic drugs.
- Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
- Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.
Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.
Show more...Investment focus
- Industry: Manufacturing, Semiconductor, Electronics
- Stage:Series A, Series B
- Geography: China, Hong Kong, Singapore
Investor stats
- Total investments: 270
- Round size: Series A $1.4M–$28M; Series B $11M–$43M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Heguang New Energy — Heguang New Energy is China's largest producer of square silicon cores for polysilicon and has long-term and stable purchase agreements with a number of major polysilicon producers.
- Matrix Software — Matrix Software is a research organization that focuses on the analysis, management, and prevention of information technology risks.
- Nanzhi Core Material — Nanzhi Core Material is a research and development manufacturer of optical grade lithium niobate crystal.
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: China, United States, South Korea
Investor stats
- Total investments: 372
- Round size: Series A $2.8M–$94M; Series B $12M–$113M; Series C $14M–$200M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $177M in 2021
Portfolio highlights
- Dipeak — Dipeak is a big data computing and artificial intelligence company that helps businesses traverse the AI era. Dipeak offers computer software services connected to data intelligence engines that integrate computing intelligence.
- Bespin Global — Bespin Global provides consulting, migration, managed services, and solutions for hybrid cloud. They rapidly implement architectures optimized for various industry areas into a hybrid cloud environment interacting with IDB using AWS, MS Azure, and Flexcloud. Bespin Global is a premium brand for strengthening Hostway's cloud business that hasprovided corporate professional hosting services and managed services since 1998 and is dedicated to Hostway's cloud managed service provider (MSP) business.
- Volant Aerotech — Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft.
Jan Hammer is the partner at Index and the Board observer of Harmonic. Jan attended Oxford University.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B, Seed
- Geography: China, United States, France
Investor stats
- Total investments: 72
- Round size: Seed $2.5M–$15M; Series A $2.8M–$50M; Series B $14M–$250M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Sofía — Improving the way millions of people take care of their health
- Transak — Transak offers a simple integration to allow your users to buy more than 100+ cryptocurrencies with credit/debit cards, or bank transfers in more than 120+ countries.
- Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more...Investment focus
- Industry: Medical, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: China, United States, United Kingdom
Investor stats
- Total investments: 72
- Round size: Seed $1.9M–$5.6M; Series A $2.8M–$28M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
- Tuanxiang Pharmaceutical — Tuanxiang Pharmaceutical is an innovative drug research and development company that combines traditional new drug research and development with the use of the world's leading unique phase separation technology.
- Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: China, Hong Kong, United States
Investor stats
- Total investments: 75
- Round size: Seed $8M–$21M; Series A $2.8M–$40M; Series B $11M–$60M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $69M in 2019
Portfolio highlights
- Zhuanma Biotech — Zhuanma Biotechnology is a gene editing service provider dedicated to clinically developing effective ultra-small gene editors into genetic therapeutics that are "curable once and for all."
- Excalipoint Therapetics — Excalipoint Therapeutics is a Private limited company.
- Beijing Ansong Technology — Beijing Ansong Technology Co., Ltd. is an enterprise focusing on the research and development, production, and sales of orthopedic medical devices. The company cooperates with domestic and foreign universities, research institutes, and doctors in hospitals, and is committed to creating original orthopedic products with independent knowledgeproducts.Beijing Ansong Technology was founded on June 27, 2011 by Liang Tao in Fengtai, Beijing.
Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: China, India, Canada
Investor stats
- Total investments: 129
- Round size: Seed $450k–$5M; Series A $2.8M–$17M; Series B $2.8M–$47M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Aiyisheng —
- Bingjing Smart — Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascularinterventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.
- Rushen Robotics — Rushen Robotics focuses on the domains of rehabilitation and fitness, and is committed to building modular and human-machine integrated rehabilitation robots.
Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: China, United States, India
Investor stats
- Total investments: 63
- Round size: Series A $1.4M–$76M; Series B $14M–$113M; Series C $14M–$130M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Ruijiakang — Ruijiakang focuses on the research, development, and application of green synthetic biology production, as well as the layout and research of biofuels and biomaterials for non-grain anaerobic organic alkyd pipelines, and employs Zymomonas mobilis.
- Huiguan Biology — Huiguan Biology is a developer of super-resolution microscopes for in vivo drug screening.
- JGene Biotechnology — JGene Biotechnology is a research and development biotechnology company dedicated to the research and development of universal CAR-NK/T products from iPS. It is hoped that the large-scale production of CAR-NK/T from iPS will provide cancer patients with spot-type, price-friendly, and affordable new immune cell therapy products. Recentlyreceived angel round investment.
Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 63
- Round size: Seed $7M–$13M; Series A $1.4M–$28M; Series B $14M–$462M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Fungifuture — Fungifuture is a synthetic biomaterials company specializing in the research and development and production of fungal fiber materials.
- Ruize Health — Ruize Health is a commercial insurance company that focuses on health consumption and commercial insurance.
- Huamei Haolian — Huamei Haolian specializes in providing telemedicine and medical tourism services.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 432
- Round size: Series A $2.8M–$60M; Series B $9.5M–$113M; Series C $14M–$200M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Lexin — LexinFintech Holdings is an online consumer finance platform for educated young adults in China. As one of China's leading financial technology companies, Lexin integrates its e-commerce-driven installment finance platform, Fenqile, with advanced risk management technologies, the Company's Dingsheng online investment platform, and theCompany's Juzi Licai online investment platform for individual investors, to create a comprehensive consumer finance ecosystem. The Company utilizes technologies including big data, cloud computing and artificial intelligence to enable the near-instantaneous matching of user funding requests with offers from the Company's more than 30 funding partners, which include commercial banks, consumer finance companies, and other licensed financial institutions. By serving the credit needs of China's educated young adults, Lexin helps its more than 20 million registered users to enjoy a better quality of life through the use of better credit.
- Ouli Biomedical — Ouli Biomedical is a pharmaceutical company. They offer nucleic acid drug discovery, laboratory research and development, process and analysis development, CMC services, API production, and drug registration.
- Ucello Therapeutics — Ucello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20.
Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Biotechnology
- Stage:Series A, Seed, Angel
- Geography: China, United States, Singapore
Investor stats
- Total investments: 128
- Round size: Seed $213k–$14M; Angel $425k–$2.1M; Series A $1.4M–$90M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Chuguang 3D — Chuguang 3D is a optical micro-nano 3D sensor technology platform that focuses on research and development, and manufacturing of micro-nano-level optical three-dimensional sensing and measurement and testing instruments.
- Null Hypothesis — Null Hypothesis is an AI medical SaaS company that focuses on the development of intelligent medical products using AIGC.
- Stairway Medical — Stairway Medical is a developer of implantable brain-computer interface technology.
CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: China, United States, Canada
Investor stats
- Total investments: 261
- Round size: Series A $8.3M–$198M; Series B $14M–$142M; Series C $14M–$300M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- ZSPepLib — Zonsen PepLib Biotech Inc. Zonsen PepLib Biotech Inc. is a high-tech biopharmaceutical enterprise that is dedicated to advancing global innovation in the discovery of new peptide drugs. Founded in September 2017, PepLib is headquartered in Zhuzhou, China, with a subsidiary in New Jersey, USA.
- Vision Medicals — Vision Medicals is a provider of pathogenic gene diagnostic services, focusing on infection-precise medical treatment, high-throughput sequencing-based pathogen metagenomics and CRISPR-based rapid diagnosis and other new technologies, effectively improving the detection ability of clinical pathogens and shortening The reporting cycle acceleratedthe development of the infection-accurate medical industry. The company developed a pathogenic nucleic acid enrichment technology with independent intellectual property rights for the detection of pathogenic micronucleic acids in clinical samples. The pathogen macro was established through the accumulation of pathogen detection big data. Genomics intelligent analysis and reporting system.
- Aibo Medical Robot — Aibo Medical Robot was established in Shenzhen in June 2020, focusing on the vascular interventional surgery robot market. It is reported that behind this "new" company is the accumulation of years of scientific research and technology - that is , the nearly 30 years of research and development accumulation of the founding team.
SZHTI Group is a company that provides asset management and financing services.
Show more...Investment focus
- Industry: Manufacturing, Electronics, Semiconductor
- Stage:Series A, Angel
- Geography: China, United States
Investor stats
- Total investments: 117
- Round size: Angel $425k–$1.4M; Series A $780k–$14M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Elegoo — ELEGOO specializes in the research, development, and production of the most quality & affordable 3D printers, Arduino-based STEM & robotic kits, making technology easy-to-access for all the makers around the world.
- Junyi Technology — Shenzhen Junyi Technology Co., Ltd. is one of the world's leading OLED vapor deposition metal mask manufacturers. Its business includes OLED metal mask R&D, production and manufacturing, as well as supporting cleaning and maintenance services. Its customers cover CSOT, Truly Semiconductor, Royole Technology, Wuhan Tianma, BOE and otherdomestic OLED panel companies.
- Zhiqin Instruments — Zhiqin Instruments is an instrument supplier that offers full solutions for analysis and testing to important industries based on its own rapid detection mass spectrometer.
Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: China, United States, Canada
Investor stats
- Total investments: 183
- Round size: Series A $1.7M–$43M; Series B $10M–$100M; Series C $14M–$200M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- TuringQ — Established in February 2021, TuringQ is committed to the research of quantum information. Through the R&D of lithium niobate on insulator (LNOI) photonic chips and femtosecond laser direct writing technology, the photon chips that enable large-scale photonic circuits integration can be prepared and an optical quantum system with a whole newlevel of scale and complexity can be built. At present, TuringQ has achieved leading advantages in photonic quantum chips, scientific research-grade photonic quantum computers, photonic quantum measurement and control systems, photonic quantum EDA software, and photonic quantum cloud platforms.
- Gazer — Gazer is a semiconductor equipment and sensor developer, focusing on the research and development, and innovation of sensing and control technology.
- Supermag — Suzhou Supermag Intelligent Technology Co., Ltd. (hereinafter referred to as Suci Technology) is committed to the research and development, production and sales of maglev high-speed motors. With the design authorization of magnetic levitation compressors, magnetic levitation blowers, magnetic levitation pumps, etc., it provides core components suchas magnetic levitation motors, magnetic levitation bearings, magnetic levitation controllers, and displacement sensors.
Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series B, Series A, Seed
- Geography: China
Investor stats
- Total investments: 31
- Round size: Seed $1.4M–$14M; Series A $1.4M–$14M; Series B $2.8M–$28M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Aopeng Yiliao — Aopeng Yiliao is a developer of vascular interventional surgery robots.
- Bochuang Biotechnology — Bochuang Biotechnology is a cutting-edge medical repair product developer that specializes in the controllable electrochemical assembly of biomacromolecules. Bochuang Biotechnology is creating a line of high-end biological tissue functional membranes and derived medical device solutions.
- Yangshan Medical Technology — Yangshan Medical Technology is a Shanghai-based company specializing in dental surgery robots.
SND Ventures Group is a venture capital and private equity firm specializing in seed investments.
Show more...Investment focus
- Industry: Manufacturing, Semiconductor, Health Care
- Stage:Series A, Series B, Seed
- Geography: China
Investor stats
- Total investments: 72
- Round size: Series A $1.4M–$43M; Series B $709k–$90M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Dezhi Matrix — Dezhi Matrix is focused on the larger semiconductor area, dedicated to constructing multimodal large-scale AI industrial models and delivering an AI-powered quality inspection solution.
- Sicui Thermal Control — Sicui Thermal Control focuses on the design of next-generation semiconductor and microelectronics thermal management solutions.
- Gongji Technology — Gongji is a technology-based company specializing in multi-source information fusion and positioning for intelligent vehicles.
Goldport Capital is a Shenzhen-based asset management company.
Show more...Investment focus
- Industry: Manufacturing, Medical, Semiconductor
- Stage:Series A, Seed, Angel
- Geography: China
Investor stats
- Total investments: 60
- Round size: Seed $1.4M–$14M; Angel $425k–$14M; Series A $1.4M–$55M
- Lead/follow: 52% lead, 48% follow
Portfolio highlights
- Tianyuanxing — Tianyuanxing is a general industrial embodied intelligent platform developer whose primary focus is on the research and development of the "TX01" wheeled chassis humanoid dual-arm robot.
- Hangzhou Atom — Hangzhou Atom focuses on the R&D of atomic-level high-end materials manufacturing equipment, specializing in vacuum chemical vapor deposition
- Rongxin New Materials — Rongxin New Materials is a developer specializing in graphene material science and technology, with a commitment to the research and development of new materials technology and engineering applications. The company focuses on graphene-based heating films and graphene-integrated thermal products that are designed to provide efficient and uniformheating solutions for both consumer and industrial sectors.
Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry, including biopharmaceuticals, life sciences, medical devices, medical services, and diagnostics.Founded in 2015, Apricot Capital consists of more than 20 professionals and consultants with experience in thehealthcare industry. Its professional background includes life sciences, medicine, finance and law.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 41
- Round size: Seed $10M–$28M; Series A $3M–$54M; Series B $14M–$58M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Vibrant — Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines. The company will use artificial intelligence algorithms to accelerate the efficiency of drug development in various aspects such as target discovery, drug design, and drug efficacy evaluation; at the same time, the company expects tocontinuously improve the success rate of drug development through sustainable data accumulation and algorithm optimization.It was founded and headed by Dr. Wang Luquan and is based in Guangzhou, Guangdong, China.
- Qihe Biotech — Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.
- LyncBio Therapeutics —
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Fortune Capital, established in April, 2000, is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focus its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture and Clean Tech.Fortune Capital is ranked among thehighest performing VC/PE firms in China and selected as "Vice President of Venture Capital Committee of IAC," "Vice President of Shenzhen VC Association," "Vice President of Shenzhen Chamber of International Investment & Funding," etc.In addition to providing capitals, Fortune Capital provides its investee companies with personalized value-added services.
Show more...Investment focus
- Industry: Manufacturing, Software, Information Technology
- Stage:Series A, Series B, Seed
- Geography: China, Japan, United States
Investor stats
- Total investments: 234
- Round size: Seed $425k–$73M; Series A $1.4M–$40M; Series B $2.8M–$56M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $780M in 2021
Portfolio highlights
- Picea Motion — Picea Motion is a precision harmonic drive company that specializes in the development and production of harmonic speed reducers.
- Deep Robotics — Deep Robotics specializes in the application of the global quadruped robot industry. The founding team is rooted in Zhejiang University and has more than ten years of robotics research and development background. It is a high-tech company that attaches great importance to research and development and takes core technology as its maincompetitiveness. Sunshine has mastered the key core technology of quadruped robot motion control and has a number of independent and controllable intellectual property rights. The self-developed "Jueying" series of robots have reached the advanced level among similar products in the world and has been the first to be put into use in electric power, tunnel, fire protection, security, and other fields. Since its establishment in 2017, Yunshen has completed the R&D and sales layout of four series of products conducted multiple rounds of financing and built a complete organizational system. With the increasingly mature application of the quadruped robot industry, the company has entered a channel of rapid development.
- Tongli Haiyuan Biotechnology — Tongli Haiyuan Biotechnology focuses on the R&D and production of GMP-grade core raw material reagents for upstream cell and gene therapy.
HY Capital is a healthcare industry-focused investment firm that engages in early-stage investments, growth-stage investments.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Seed, Series B
- Geography: China, United States
Investor stats
- Total investments: 20
- Round size: Series A $199k–$16M; Series B $14M–$28M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- Kang Ruijian — Kang Ruijian is a developer of thermosensitive modified chitin hydrogel technology.
- Onico Medical — Onico Medical is a medical device developer. The core team comes from the serious medical field and has absorbed professionals with rich experience in medical aesthetics development.
- Linyan Medical — Linyan Medical is a high-tech company focusing on the combination of man and machine in metaverse medical surgery.
By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Biotechnology
- Stage:Series A, Seed, Angel
- Geography: China, United States, Singapore
Investor stats
- Total investments: 194
- Round size: Seed $1.4M–$14M; Angel $425k–$17M; Series A $1.4M–$35M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $130M in 2015
Portfolio highlights
- SoundAI — Sound Technology is a science and technology innovation company that specializes in acoustics frontier technology and artificial intelligence interaction. It is committed to lead the more interactive experience of artificial intelligence in the real environment and realize the human-computer interaction vision that "listen to you and know whatyou think".
- Jiajin Biotech — Jiajin Biotech is a pharmaceutical R&D service provider. It specializes in the development of antibody-small nucleic acid conjugates.
- Optical Standard Technology — Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security.
Shenzhen Green Pine Capital Partners Co. Ltd. (“GPCP”) was established in 2007, with the investment team assembled in 2000. GPCP is one of the most time-honored Chinese VC companies that boast experience in areas such as biotech, new materials, new resources and AI, etc. Currently, GPCP manages assets over 15 billion RMB through 21 special fundsand have invested 7 billion RMB into 388 enterprises among which 14 are listed on NEEQ and 48 of them are either listed or acquired by listed companies, including BGI(300676.SZ), Aurora(600666.SH), Nationz Tech(300077.SZ), Foresee(002530.SZ), Qudian(NASDAQ:QD), etc. GPCP invested in the angel round of BGI (Beijing Genomics Institute), Royole, Kuang-Chi, Appotronics, BMF, C-one, Arrayed Materials and other star enterprises.GPCP is based in Shenzhen, with branches in Beijing, Shanghai and Guangzhou. GPCP also runs two GPI incubators and an incubator for overseas Chinese scientists who start businesses in China.
Show more...Investment focus
- Industry: Biotechnology, Software, Manufacturing
- Stage:Series A, Series B, Angel
- Geography: China, United States, Canada
Investor stats
- Total investments: 165
- Round size: Angel $425k–$2.9M; Series A $1.4M–$100M; Series B $4M–$150M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $138M in 2019
Portfolio highlights
- MindRank AI — MindRank AI is a developer of proprietary end-to-end AI-driven drug discovery platform (Molecule Pro™).
- Ruitai Biotechnology — Ruitai is a developer for ophthalmic regenerative medicine, specialising in the R&D and sale of repair materials and medical device products
- Signet Therapeutics — Signet Therapeutics is a cutting-edge firm that conducts research and development on cancer-targeted drugs using AI and organoid disease models.
Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Biotechnology
- Stage:Series A, Series B
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 102
- Round size: Series A $425k–$21M; Series B $5.7M–$60M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $73M in 2018
Portfolio highlights
- Alluxio — Accelerate AI workloads, increase GPU utilization, and reduce infrastructure costs with Alluxio's AI-optimized, highly-distributed cache.
- Triastek — Triastek develops 3D printed medicines and the production facilities to manufacture them and has already filed patent applications for its technology.
- Vision Medicals — Vision Medicals is a provider of pathogenic gene diagnostic services, focusing on infection-precise medical treatment, high-throughput sequencing-based pathogen metagenomics and CRISPR-based rapid diagnosis and other new technologies, effectively improving the detection ability of clinical pathogens and shortening The reporting cycle acceleratedthe development of the infection-accurate medical industry. The company developed a pathogenic nucleic acid enrichment technology with independent intellectual property rights for the detection of pathogenic micronucleic acids in clinical samples. The pathogen macro was established through the accumulation of pathogen detection big data. Genomics intelligent analysis and reporting system.
Insight Capital is a venture capital firm focused on early-stage investment.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Seed, Series C
- Geography: China, Thailand, United Kingdom
Investor stats
- Total investments: 24
- Round size: Seed $14M–$15M; Series A $2.8M–$14M; Series C $5.7M–$100M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $74M in 2018
Portfolio highlights
- Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
- Iongen Therepeutics — Discovery of Novel Analgesics IonGen is a biotech company dedicated to the discovery of next-generation pain therapies without the addiction liabilities and side-effects associated with opioids.
- Hangzhou Dasheng Technology — Hangzhou Dasheng is a high-tech enterprise specializing in the research and development of medical surgical robot systems, dedicated to advancing precision medicine through innovative technologies, integrating artificial intelligence, robotics, and minimally invasive surgical solutions to improve clinical outcomes, enhance surgeon capabilities, andprovide safer, more efficient healthcare services worldwide.
ASBV focuses on early and mid-term venture capital investments.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Angel
- Geography: China, Australia, Hong Kong
Investor stats
- Total investments: 27
- Round size: Seed $3M–$14M; Angel $425k–$425k; Series A $1.4M–$31M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
- Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
- Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Qiaojing Capital is an investment firm that invests in the medical, consumer & supply chain financial management industries. Qiao Jing Capital's core operation team has experience in senior management positions in well-known asset management companies at home and abroad. The company's operations fully follow the leading models athome and abroad, and pursue strict risk management and efficient incentive mechanisms.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B, Angel
- Geography: China
Investor stats
- Total investments: 14
- Round size: Series A $1.4M–$35M; Series B $9.9M–$14M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Hicicare — Hicicare is a medical technology company that specializes in the development of pan-vascular interventional medical devices.
- Yisheng Microna — Yisheng Microna is an ultrasonic transducer designer and developer, focusing on providing minimally invasive interventional ultrasonography catheters and transducers.
- Elite Technology — Elite Technology is a company that specializes in the development of chromatographic techniques, workstations, and high-performance liquid chromatography equipment for analysis, preparation, and industrial production.
Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, United States, Portugal
Investor stats
- Total investments: 140
- Round size: Seed $8.5M–$84M; Series A $2.8M–$73M; Series B $7.6M–$70M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $563M in 2021
Portfolio highlights
- Yixiu — Yixiu provides sleep health products such as smart wearables, smart home sleep scene hardware, sleep data analysis platforms, energy management apps, and more.
- Yushi Space — Yushi Space is a liquid rocket developer that focuses on the development and manufacture of large-capacity, low-cost and rapidly reusable liquid rockets.
- PoShell Robotics — PoShell Robotics is a general-purpose home robot, aiming to create a home-friendly and structurally stable robot.
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Angel
- Geography: China, United States, Germany
Investor stats
- Total investments: 129
- Round size: Angel $425k–$15M; Series A $1.4M–$63M; Series B $3.5M–$90M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $430M in 2018
Portfolio highlights
- PrinoPharma — PrinoPharma focuses on developing novel druggable sites targeting difficult-to-drug or existing druggable targets.
- Synaptic Medical — Synaptic Medical is a medical device company focused on the treatment of cardiac arrhythmias and other cardiovascular diseases.
- GenFleet Therapeutics — GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize thebody's own immune system.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Tasly Capital is an investment arm of Tasly, a Chinese pharmaceutical company.
Show more...Investment focus
- Industry: Medical, Medical Device, Health Care
- Stage:Series B, Series A, Seed
- Geography: China
Investor stats
- Total investments: 12
- Round size: Series A $14M–$15M; Series B $14M–$43M
- Lead/follow: 58% lead, 42% follow
Portfolio highlights
- PulseCare — PulseCare is a medtech company that specializes in innovative medical devices and solutions for cardiac and pan-vascular treatment.
- LeadBio Tech — LeadBio Tech is a biotechnology company that specializes in the development of bioartificial blood vessel medical devices.
- Singular Medical — Singular Medical is a technology company specializing in R&D and industrialization of cardiac rhythm management (CRM) products. The company builds a complete technical platform and is a supplier of full line of CRM products, which provides a complete range of solutions, from detection to follow-up for large amounts of cardiac patients.
Co-Stone Capital is a leading China based private equity firm headquartered in Shenzhen. Founded more than 16 years ago, Co-Stone is one of China's earliest private equity institutions. Co-Stone Capital focuses primarily on China domestic growth stage and Pre-IPO opportunities, basing investment decisions on a deep understanding of the Chineseeconomy and company specific growth patterns. We put heavy emphasis on stable growth in key industries, including TMT, healthcare, consumer products & services and advanced manufacturing. Co-Stone Capital approaches the capital markets with broad vision but detailed focus, maintaining an emphasis on value-adding services. We have invested in over 100 companies, the majority of which were lead investments and have successfully exited from 40 companies through IPO, M&A or reverse mergers. Our exit rates and ROI are far in excess of industry averages. Co-Stone Capital has assets under management in excess of 40 billion RMB, across funds covering private equity, venture capital, PIPE, M&A and fixed income. Co-Stone has a diverse capital base, with LPs ranging across large insurance groups, government guided funds, funds of funds, large corporations, entrepreneurs and high net worth individuals. Co-Stone Capital has received numerous accolades from Forbes, Zero2IPO,ChinaVenture and other industry publications which consistently rank us in the top 10. Co-Stone Capital is headquartered in Shenzhen, with offices in Beijing,Shanghai and Hefei.
Show more...Investment focus
- Industry: Manufacturing, Semiconductor, Health Care
- Stage:Series B, Series A, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 140
- Lead/follow: no public data
Portfolio highlights
- PaXini Tech — All Scenario Application—Haptic Digitization and Tactile Technology
- Ganwei Technology — Wuhan Ganwei Technology is a manufacturer of gas instruments and meters. Its main products include short optical path gas pools, online ultraviolet gas analyzers, gas sensors, oil and gas infrared spectroscopy logging tools, and high-precision automatic gas distribution instruments, etc., which are mainly used in environmental protection,Petrochemical and other fields.
- Changzhou Fuxing Mechanical and Electrical Co. — Changzhou Fuxing Mechanical and Electrical Co. manufactures servo, brushless DC, and hybrid stepper motors.
Jolmo Capital is an investment firm that provides related capital management and advisory services to new industries. As a diversified firm, Jolmo helps assist enterprises with rapid growth primarily through venture capital and in collaboration with other financial instruments.Jolmo Capital was founded in 2004 and is based in Nanjing, JiangsuProvince in China.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Medical
- Stage:Series A, Seed, Series B
- Geography: China, Japan, United States
Investor stats
- Total investments: 40
- Lead/follow: no public data
Portfolio highlights
- BIOSURF — BIOSURF is an innovation-driven healthcare based surface modification technology company.
- ASPIRING — Weichong Semiconductor is a semiconductor testing equipment manufacturer, dedicated to developing advanced material testing technology.
- Deli Smart Logistics Technology — Deli Smart Logistics Technology is a smart warehousing logistics system and equipment integrator specializing in smart manufacturing and logistics.
ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: China, United States, India
Investor stats
- Total investments: 121
- Lead/follow: no public data
Portfolio highlights
- Pixmoving — PIX Moving develop and manufacture the next-gen smart vehicles powered by its proprietary Ultra-skateboard chassis platform. PIX is an innovator and global leader of groundbreaking smart connected vehicles. Based on the research and development of PIX Ultra-skateboard chassis platform, a wide range of purpose-built robo-vehicles, commercialvehicles and passenger cars can be built and developed. Currently PIX products have expanded to 20 countries around the world and the company is growing rapidly. With the modular architecture, PIX products are more smart and flexible, covering 30+ application scenarios worldwide, which makes PIX a full-stack autonomous driving company with the most versatile scenario solutions. Moreover , PIX has developed the award-winning large-scale in-house metal 3D printing system, the dieless forming system as well as the real-time manufacturing. Combined with its patented vehicle generative design algorithms, PIX is capable of reducing vehicle parts and the assembly work by 70%, which enables easier maintenance and meanwhile disrupts the automotive industry from design to manufacturing, beaconing the next-generation of smart vehicle production.
- Stial — Stial is a manufacturer of adaptable polishing robots.
- Prim Semiconductor — Prim Semiconductor specializes in ultra-high precision motion solutions, wafer transfer (EFEM), precision parts production, and comprehensive equipment research and development. The company focuses on providing integrated solutions across various sectors, including semiconductors, integrated circuit (IC) manufacturing, and new energy applications.
CMB International Capital Corporation is an investment banking firm that offers comprehensive professional services and financial advisory services. It provides mergers and acquisitions, initial public offering, equity underwriting, company restructuring, project financing, and business consulting services. CMB International Capital Corporationprovides corporate finance, asset management, wealth management and securities brokerage services. Additionally, it offers debt financing and transaction advisory services, placement of shares and refinancing for listed companies. CMB International Capital Corporation’s clientele include institutional, corporate and individual customers both domestic and overseas. It began operation in 1987, with its headquarters in Central in Hong Kong as a subsidiary of China Merchants Bank.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Health Care
- Stage:Series B, Series A, Series C
- Geography: China, United States, Japan
Investor stats
- Total investments: 105
- Lead/follow: no public data
Portfolio highlights
- Daimeng Robot — Daimeng Robot is dedicated to creating multi-series general-purpose humanoid robot products that are actually commercially available and concentrate on their research and production. It offers a comprehensive selection of goods and cutting-edge answers for situations including intelligent manufacturing, logistics, and commercial services.
- Damo Intelligent Control — Damo Intelligent Control is a national specialized "little giant" enterprise and a national high-tech enterprise focusing on the research and development, production, sales, and service integration of drone cluster automation performance systems. It is the world's leading supplier of drone cluster automation performance systems.
- NAEN Auto Technology — Shanghai NAEN Auto Technology co.Ltd provides automotive electronics products for automobile manufacturers.
Qingrong Ventures is an Investment firm.
Show more...Investment focus
- Industry: Medical, Medical Device, Health Care
- Stage:Seed, Angel
- Geography: China
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- BrainThink — BrainThink integrates wearable sensors to deliver scalp electroencephalogram (EEG) and heart rate variability (HRV). BrainThink provides fast assessment for depression, anxiety, motor imagery, and attention.
- Yuansheng Intelligence — Yuansheng Intelligence is a manufacturer of intricate rehabilitation and nursing medical hardware.
Yuanhui Chuangyi is an investment firm.
Show more...Investment focus
- Industry: Medical Device, Beauty, Industrial
- Stage:Seed, Series A
- Geography: China
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Toll PATEO — Toll PATEO is a natural science, medical research and experimental development service provider.
- Yuewei Medical — Yuewei Medical is a developer of cardiac surgery interventional medical devices.
- Xijian Technology — Xijian Technology is committed to advancing the industrialization of innovative human biomechanics imaging technology. It focuses on health disciplines such as sports rehabilitation, dermatology and beauty, and disease diagnosis and treatment.
Long Hill Capital is a next generation thesis-driven venture capital firm. We invest in technology-enabled healthcare and consumer services companies which seek to massively improve health and quality of life for every Chinese.Since 2005 the founding team of Long Hill Capital have led the China investing practice for New Enterprise Associates(NEA), a global investment firm with over $17 billion in committed capital. They are joined by an experienced team of investment and operations professionals from such firms as Matrix Partners China and Morningside VC. Together the Long Hill Capital team have over 30 years of China venture capital experience and over 15 years of senior operating experience at some of China’s most successful technology and healthcare companies including Alibaba, Huawei and Ping’an Good Doctor.Over the course of their venture capital careers, the Long Hill Capital team have invested in such industry leading companies as CITIC Pharmaceutical, WeDoctor, Hygeia Medical Services, GST Clinics, LineKong, LianLian Pay, Ele.Me, TheBeastShop and more.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A, Series B, Angel
- Geography: China, United States
Investor stats
- Total investments: 32
- Lead/follow: no public data
Portfolio highlights
- Qingyun Technology — Qingyun Technology is an artificial intelligence digital marketing platform company focusing on the pharmaceutical industry.
- Shengnuo Medical — Sono Medical is a biomedical technology company that focuses on R&D, design, production and sales of edical equipment in the field of cardiovascular diseases.
- Wangli Technology — Wangli Technology is a digital therapy technology platform for mental illness focusing on exploring the field of human brain and spirit.
Tiantu Capital is a venture capital association.
Show more...Investment focus
- Industry: Food and Beverage, E-Commerce, Health Care
- Stage:Series A, Series B, Series C
- Geography: China, United States, Japan
Investor stats
- Total investments: 118
- Lead/follow: no public data
Portfolio highlights
- Recorna Bio — Recorna Bio specializes in biotechnology, focusing on RNA editing and genome modifications through advanced research and development. They aim to innovate in genetic engineering, contributing to advancements in biomedicine and agriculture with cutting-edge technologies and scientific expertise.
- RIGHTWAY — Ruiwei New Materials is a developer of biodegradable materials focused on applying them to the consumer market. It provides end-brand customers with integrated solutions from laboratory research and development to material processing and manufacturing.
- Xellar Biosystems — Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.
Jinding Capital is a leading industrial equity investment institution in China.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Pet
- Stage:Series A, Series B, Seed
- Geography: China
Investor stats
- Total investments: 61
- Lead/follow: no public data
Portfolio highlights
- Himiao — Himiao is a pet industry-focused company that offers pet items. its aim to create a healthier and happier life for pets and pet lovers.
- Huaban Biotechnology — Huaban Biotech is dedicated to the innovative research and development of new materials for medical aesthetics.
- Accelerating Evolution — Accelerating Evolution is a humanoid robotics company. It provides humanoid robots to AI firms and research institutes, as well as quick mass production and supply of standard items.
Medical Device Investor funding in China at a glance
Stats across 906 deals from 1.1k investors.
Access all 1115 investors in China Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device Investors in China investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 1115 investors investing in China Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!